Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Little

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Seminars in Arthritis and Rheumatism|July 20, 2015
DXA in the assessment of subchondral bone mineral density in knee osteoarthritis--A semi-standardized protocol after systematic reviewAlexandre Sepriano, Jorge A Roman-Blas, Robert D Little, et al.
Current Pain and Headache Reports|December 11, 2021
Non-pharmacologic and Mindful-Based Approaches for Pediatric Headache Disorders: a ReviewReena Gogia Rastogi, Tava L Arnold, Clarimar Borrero-Mejias, et al.
BMC Musculoskeletal Disorders|August 24, 2020
Association between increased signal intensity at the proximal patellar tendon and patellofemoral geometry in community-based asymptomatic middle-aged adults: a cross-sectional studyRobert D Little, Samuel E Smith, Flavia M Cicuttini, et al.
Egastroenterology|February 13, 2025
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directionsRobert D Little, Thisun Jayawardana, Sabrina Koentgen, et al.
Inflammatory Bowel Diseases|November 11, 2023
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter StudyRobert D Little, Adrian Swaine, Rebecca Reynolds, et al.
Digestive Diseases and Sciences|January 3, 2026
Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab DosingRyan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Journal of Crohn'S & Colitis|May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort AnalysisRobert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Nutrients|January 8, 2025
Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern AnalysisDenelle Cosier, Kelly Lambert, Karen Charlton, et al.
The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Seminars in Arthritis and Rheumatism|July 20, 2015
DXA in the assessment of subchondral bone mineral density in knee osteoarthritis--A semi-standardized protocol after systematic reviewAlexandre Sepriano, Jorge A Roman-Blas, Robert D Little, et al.
Current Pain and Headache Reports|December 11, 2021
Non-pharmacologic and Mindful-Based Approaches for Pediatric Headache Disorders: a ReviewReena Gogia Rastogi, Tava L Arnold, Clarimar Borrero-Mejias, et al.
BMC Musculoskeletal Disorders|August 24, 2020
Association between increased signal intensity at the proximal patellar tendon and patellofemoral geometry in community-based asymptomatic middle-aged adults: a cross-sectional studyRobert D Little, Samuel E Smith, Flavia M Cicuttini, et al.
Egastroenterology|February 13, 2025
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directionsRobert D Little, Thisun Jayawardana, Sabrina Koentgen, et al.
Inflammatory Bowel Diseases|November 11, 2023
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter StudyRobert D Little, Adrian Swaine, Rebecca Reynolds, et al.
Digestive Diseases and Sciences|January 3, 2026
Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab DosingRyan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Journal of Crohn'S & Colitis|May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort AnalysisRobert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Nutrients|January 8, 2025
Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern AnalysisDenelle Cosier, Kelly Lambert, Karen Charlton, et al.
The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Pageof 2